Eligible patients who signed the informed consent were randomly assigned into two treatment groups : an experimental group ( Spasmofen group ) who received one Spasmofen rectal suppository plus an IV injection of @ mL of normal saline solution ; and a control group ( ketorolac group ) who received one ketorolac @ mg/@ mL ampoule IV plus one placebo suppository .